share_log

YS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)

YS Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)

YS Biopharma | SC 13D:超过5%持股股东披露文件-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)
美股SEC公告 ·  02/14 11:27
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息